Cargando…
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Lung cancer is the leading cause of cancer-related deaths worldwide. Immune checkpoint inhibitors, including monoclonal antibodies against programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1), have dramatically improved the survival and quality of life of a subset of non-small cell lung c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185359/ https://www.ncbi.nlm.nih.gov/pubmed/34113560 http://dx.doi.org/10.3389/fonc.2021.635007 |